United States · 
Who invested in Transposon Therapeutics?
Transposon Therapeutics's investors include Canaan and SV Health Investors.
United States · Funded startup
Who invested in Transposon Therapeutics
Funding summaryUpdated 26 Oct 2026
$22Mraised across 1 round since 2026, from 1 source
- Latest round
- Grant, $22MMar 2026
- Investors
- 2
The rounds
- Mar 2026
Founders and team
From Transposon Therapeutics's own website: 5 on the team.
- Dennis PodlesakCEO and Chair
- Lynne RollinsChief Financial Officer
- Brent AhrensDirector
- John PacificoDirector
- Keith KatkinDirector
Everyone who backed them
SV Health InvestorsVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Transposon Therapeutics
How much has Transposon Therapeutics raised?
Transposon Therapeutics has raised $22M across 1 round since 2026.
When did Transposon Therapeutics last raise?
Transposon Therapeutics's most recent round was a Grant of $22M in Mar 2026.
What was Transposon Therapeutics's biggest round?
Its most recent round, $22M in Mar 2026, is also its largest on record.
Who backed Transposon Therapeutics first?
Transposon Therapeutics's first round on record, in Mar 2026, was backed by Canaan and SV Health Investors.
What stage is Transposon Therapeutics at?
Transposon Therapeutics's latest named round is a Grant, in Mar 2026.
Where is Transposon Therapeutics based?
Transposon Therapeutics is based in the United States.
Companies like Transposon Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.